AutekBio To Set Up Biologic CMO Facility In China
The new R&D facility will service international biologic developments, with combined volumes of bioreactors up to 20,000lt in multiple production lines (trains). Julius Li, CEO of AutekBio, said
Life sciences and technology companies supported by the Ontario Bioscience Innovation Organization’s (OBIO) Capital Access Advisory Program (CAAP) have collectively raised more than C$1bn ($704.7m) in capital.
Maybridge claimed that the Ro3 500 Fragment Library, selected from the original Maybridge “Rule-of-Three” (Ro3) compliant set, is designed to be a convenient, cost-effective entry point to fragment